Antidote is committed to creating, developing, and operating high-quality, relevant, and practical continuing medical education activities that are in compliance with the ACCME's policies on commercial support and disclosure. Specifically, we are dedicated to ensuring that our activities are planned and implemented free of the control of commercial interests. To this end, Antidote requires everyone who is in a position to influence the content of an activity to disclose all relevant relationships with commercial interests. Antidote then seeks to resolve these conflicts. Any person who refuses to disclose their relationships, or whose conflicts cannot be resolved may not participate in the activity. In addition, it is our standard practice to disclose all relevant financial relationships of our faculty in writing to our attendees before the beginning of an educational activity.
Antidote also requires that faculty disclose to the participants when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
The planning staff of Antidote Medical Education Company, and RealCME have no commercial relationships to disclose.
Individuals in a position to control the content of this activity reported the following relevant financial relationships with commercial interests:
Elena M. Massarotti, MD has disclosed the following relationships:
Consulting Fee(s): Sanofi Aventis, Biogen
Research/Grant(s): Bristol-Myers Squibb, Human Genome Sciences
Jonathan Kay, MD has disclosed the following relationships:
Consulting Fee(s): Bristol-Myers Squibb
Research/Grant(s): Abbott Laboratories, Eli Lilly, Pfizer, Sanofi-Aventis
Vivian P. Bykerk, BSc, MD, FRCPC has disclosed the following relationships:
Honorarium: Bristol-Myers Squibb
Consulting Fee(s): Amgen, Augurex, Crescendo, Gennentech, Merck, Pfizer, Roche, UCB
Research/Grant(s): Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Gennentech, Johnson & Johnson, Pfizer, Roche, UCB
Other: Data Safety Monitoring Board, Spouse Novartis Employee and owns stock
The following individuals have indicated no conflict of interest disclosures to report: Michael O. Fleming, MD FAAFP
(Course Director) Leigh McKinney
(Editor) Matthew Fleming
(Vice President, Antidote Education Company)
OFF-LABEL OR INVESTIGATIONAL PRODUCT DISCUSSION
All faculty have indicated that this enduring material does not include the off-label/investigational use of a commercial product or device. DISCLAIMER
The opinions and recommendations expressed by faculty in this activity are their own and do not necessarily represent the views of Antidote Education Company, and RealCME. Please review complete prescribing information for specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.
ACCME: Antidote Education Company is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Antidote designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 0.50 hours of Category I credit for completing this program.
HOW TO RECEIVE CREDIT
There are no fees for participating in and receiving credit for this activity. The participant must read the learning objectives and enduring material and must answer the multiple-choice online post-test. Please complete the evaluation form, which provides each participant with the opportunity to comment on the quality of the instructional process, the perception of enhanced professional effectiveness, the perception of commercial bias, and his/her views on future educational needs. A score of at least 65% is required to successfully complete this activity. The participant may take the test until successfully passed. Credit is available through August 19, 2015.
COURSE VIEWING REQUIREMENTS
|Supported Browsers: |
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 5.0+ for Mac OSX 10.5 and above
For video playback, install the latest version of Flash or Quicktime.
|Supported Phones & Tablets: |
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Release Date: June 12, 2014
Expiration Date: August 19, 2015
Copyright © 2014-2015 Antidote Education Company. All rights reserved. No part of this material may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations.
If you have questions about this CME activity, please Antidote at 888-692-2631 or email@example.com.
This activity is made possible by an educational grant from Bristol-Myers Squibb.